Page 52 - Sohini Das

Around 21 API projects come up under the PLI scheme, shows data

These units have an installed capacity of 33,895 tonnes

Domestic auto parts makers benefit from supply disruptions from China

While they have not been able to make a huge dent globally, their operations have grown with OEMs in India beginning to lean on them more heavily for supplies

2022: When India learnt to live with Covid as the virus eased its grip

The health sector returned to the old normal; the advice for 2023 is 'watchfulness and appropriate response'

Syrup deaths in Uzbekistan: Pharmexcil suspends Marion Biotech's membership

Co grew rapidly in the last four-five years; primarily makes cold medication

Timely resolution of FDA action crucial to Indian pharma's US pipeline

Analysts say overall risks remain high for US generics business

India to require Covid test for arrivals from China, 4 other Asian nations

Health Minister Mandaviya asks pharma firms to ensure adequate stock of Covid-19 drugs

Cough syrup deaths: Centre, UP team inspect pharma firm's Noida unit

Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis

After Gambia, now Uzbekistan alleges Indian cold drug killed its children

Noida-based Marion Biotech's Dok-1 Max anti-cold medicine under scanner after the Central Asian nation blames it for 18 deaths

Daily vaccination rates in India surge two-fold amid global Covid scare

This despite an infection rate of about 150-200 cases a day; Vaccine makers say there are sufficient stocks to meet rising demand

Corporate India gears up to hedge China supply risk amid Covid surge

The sectors in India that import from China include pharmaceutical (pharma), automotive (auto), textile, engineering, and electronic goods

2022: When the pendulum moved from great resignation to great return

The controls are back with employers, and WFO with a degree of flexibility is the office-way for now

Doctors urge govt to allow fourth booster dose for medical fraternity

They say protective effect of vaccine lasts nine months to a year. For health workers that period is already over and this is the right time to boost their immunity

Bharat Bio's nasal Covid vaccine to cost Rs 800/dose in private market

Price at Rs 325 per dose for large-volume government procurement, will be on sale late January

Deja-vu moment as govt hospitals start mock drills to test Covid infra

India has 3,421 active Covid-19 cases currently, and reported 157 fresh cases in the last 24 hours

CDSCO, states begin joint checks of drug-making units across India

Objective of drug regulation is to ensure safety, efficacy, and quality of drugs

India Inc takes steps to protect supply chain as Covid-19 rages in China

Keeps adequate inventory levels for now; onboards multiple vendors to mitigate risk

Kinetic to start producing electric version of Luna at Ahmednagar plant

Company set ups dedicated production line with an initial capacity of 5,000 sets per month

Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 crore

To launch open offer for another 26%; plans merger with Cohance

We aim to be one of India's top CDMO, API players: Advent's Shweta Jalan

'Suven alone has multiple engines of growth across all segments and a strong pipeline of Phase 3 and late Phase 2 molecules'

Hyderabad-based drug major Hetero prices Paxlovid generic at $60 per course

Generic version of Pfizer's Covid antiviral treatment would be exported for $70